- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 44.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 40.01M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 31.78M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.67M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.76M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.12M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $6.79M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.62M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $10.11M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.4M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.29M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $12.84M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $16.72M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.36M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $45.63M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $31.86M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.58M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $992.6K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $208.79K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $607.37K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.23M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$1.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.14M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.6M |
| Revenue | Q1 2026 · Mar 31, 2026 | $132.97K |